HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13
May 04, 2021 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 04, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will...
HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results
April 05, 2021 16:03 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain...
HTG Molecular Diagnostics Reports Full Year 2020 Results
March 25, 2021 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 25, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its...
HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25
March 16, 2021 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will...
HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology
February 26, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Feb. 26, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has...
HTG Announces Board of Directors Transition
January 19, 2021 16:10 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Jan. 19, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that...
HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results
January 05, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
Preliminary full year 2020 unaudited revenue of $8.5 million Cash, cash equivalents and short-term marketable securities of $28.7 million as of December 31, 2020 TUCSON, Ariz., Jan. 05, 2021 ...
HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants
December 30, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel
December 18, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel
December 08, 2020 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 08, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...